Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
24
Number of overlapping holdings
18.5%
% of XBI's 131 holdings also in CANC
53.3%
% of CANC's 46 holdings also in XBI
Overlap by Weight
Sector Drift (XBI minus CANC)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XBI |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
REVOLUTION MEDICINES, INC. | 1.3% | 3.1% | 1.3% |
|
EXACT SCIENCES CORP | 1.2% | 3.1% | 1.2% |
|
EXELIXIS INC | 1.2% | 2.4% | 1.2% |
|
MODERNA, INC. | 1.1% | 2.0% | 1.1% |
|
BLUEPRINT MEDICINES CORP. | 1.1% | 2.6% | 1.1% |
Position Highlights (Non-Overlapping Exposures)
XBI Overweight Relative to CANC
|
NIVALIS THERAPEUTICS INC | 1.9% |
|
BIOMARIN PHARMACEUTICAL INC | 1.2% |
|
CYTOKINETICS INC | 1.2% |
|
CEREVEL THERAPEUTICS HOLDINGS INC | 1.2% |
|
CRINETICS PHARMACEUTICALS INC | 1.2% |
|
AMGEN INC | 1.1% |
 |
ROIVANT SCIENCES LTD. | 1.1% |
|
UNITED THERAPEUTICS CORP | 1.1% |
|
GERON CORP | 1.1% |
|
ALNYLAM PHARMACEUTICALS INC | 1.1% |
XBI Underweight Relative to CANC
|
MERCK & CO. INC. | -5.6% |
|
REGENERON PHARMACEUTICALS | -4.5% |
 |
DAIICHI SANKYO CO LTD | -4.0% |
|
ASTRAZENECA PLC | -3.8% |
 |
NOVARTIS AG | -3.7% |
|
ILLUMINA INC | -3.5% |
 |
ARGENX SE ADR | -2.9% |
|
CHUGAI PHARMACEUTICAL CO LTD | -2.7% |
|
BRISTOL-MYERS SQUIBB CO | -2.5% |
 |
GENMAB A/S SPONSORED ADR | -2.1% |